# Chinese yam polysaccharide promotes jejunal development, antioxidant defense, and mucosal immunity in weaned rats

**Authors:** Chuanyan Che, Ya Yang, Hong Hu, Mengmeng Jin, Shenghe Li, Ahmed H. Ghonaim, Mai G. Hopo, Changsheng Jiang, Man Ren

PMC · DOI: 10.3389/fvets.2026.1721855 · Frontiers in Veterinary Science · 2026-02-03

## TL;DR

Chinese yam polysaccharide improves gut health, antioxidant defenses, and immune function in weaned rats.

## Contribution

This study reveals the novel role of Chinese yam polysaccharide in enhancing jejunal development and mucosal immunity in weaned rats.

## Key findings

- CYP supplementation increased antioxidant capacity and reduced oxidative stress in weaned rats.
- CYP improved jejunal morphology and mucosal immunity by upregulating IgA and β-defensin levels.
- CYP enhanced digestive enzyme activity and strengthened intestinal barrier function via Claudin-1 and Mucin-1 upregulation.

## Abstract

Chinese yam polysaccharide (CYP), a heteropolysaccharide composed of mannose, xylose, arabinose, glucose, and galactose, has been reported to exhibit immunomodulatory and antioxidant properties. However, its role in regulating intestinal development and mucosal barrier function remains incompletely understood. This study investigated the effects of dietary CYP supplementation on antioxidant status, jejunal morphology, digestive function, and mucosal immunity in weaned rats.

Thirty specific-pathogen-free male Sprague–Dawley rats (initial body weight: 50.16 ± 0.50 g) were randomly assigned to three dietary groups (n = 10 per group) for a 28-day feeding trial: a control group fed a basal diet and two treatment groups fed the basal diet supplemented with 0.1% or 0.5% CYP. At the end of the experiment, blood and jejunal tissues were collected for biochemical, histomorphological, and molecular analyses.

Compared with the control group, supplementation with 0.5% CYP significantly reduced plasma malondialdehyde (MDA) concentrations (P < 0.05) and increased total antioxidant capacity (P < 0.01), which was associated with activation of the MAPK ERK1/2–Nrf2 signaling pathway. Both 0.1% and 0.5% CYP supplementation significantly increased jejunal villus height and the villus height-to-crypt depth ratio (P < 0.05), while reducing intraepithelial lymphocyte numbers (P < 0.05). Moreover, rats receiving 0.5% CYP exhibited significantly higher activities of lactase, sucrase, and maltase, along with increased jejunal immunoglobulin A (IgA) and β-defensin levels (P < 0.05 or P < 0.01). Additionally, CYP supplementation at both inclusion levels markedly upregulated the expression of Claudin-1 and Mucin-1 (P < 0.01).

Collectively, these findings demonstrate that dietary CYP enhances systemic antioxidant defense, promotes jejunal structural development, and strengthens intestinal mucosal barrier function in weaned rats.

## Linked entities

- **Proteins:** CD79A (CD79a molecule), CLDN7 (claudin 7), Muc1 (mucin 1, cell surface associated), GABPA (GA binding protein transcription factor subunit alpha), erk1/2 (mitogen-activated protein kinase)
- **Chemicals:** malondialdehyde (PubChem CID 10964)

## Full-text entities

- **Genes:** Lct (lactase) [NCBI Gene 116569] {aka Lph}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Muc1 (mucin 1, cell surface associated) [NCBI Gene 24571], Cyp3a23-3a1 (cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1) [NCBI Gene 25642] {aka AABR07035343.1, CYP, CYP3A23, Cyp3a1, Cyp3a23/3a1, Cyp3a3}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Kit (KIT proto-oncogene receptor tyrosine kinase) [NCBI Gene 64030], Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Defb1 (defensin beta 1) [NCBI Gene 83687] {aka CDK4}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Cldn1 (claudin 1) [NCBI Gene 65129]
- **Diseases:** mucosal injury (MESH:D052016), enteritis (MESH:D004751), bacteremia (MESH:D016470), diarrhea (MESH:D003967), fatigue (MESH:D005221), inflammation (MESH:D007249), cancer (MESH:D009369)
- **Chemicals:** citrate (MESH:D019343), bicinchoninic acid (MESH:C047117), polyphenols (MESH:D059808), xylose (MESH:D014994), arabinose (MESH:D001089), lipopolysaccharide (MESH:D008070), sucrose (MESH:D013395), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), polyvinylidene difluoride (MESH:C024865), Tween-20 (MESH:D011136), ROS (MESH:D017382), diethyl ether (MESH:D004986), glucose (MESH:D005947), flavonoids (MESH:D005419), H&amp;E (MESH:D006371), hydrogen peroxide (MESH:D006861), CYP (-), Na+/ (MESH:D012964), hematoxylin (MESH:D006416), phenylmethylsulfonyl fluoride (MESH:D010664), MDA (MESH:D008315), carbohydrate (MESH:D002241), water (MESH:D014867), NEFA (MESH:D005230), SDS (MESH:D012967), copper (MESH:D003300), galactose (MESH:D005690), ethanol (MESH:D000431), mannose (MESH:D008358), saline (MESH:D012965), Paraffin (MESH:D010232), ammonia (MESH:D000641), nitrogen (MESH:D009584), polysaccharide (MESH:D011134), xylene (MESH:D014992), polyacrylamide (MESH:C016679)
- **Species:** Dioscorea oppositifolia (species) [taxon 569628], Echinacea (genus) [taxon 53747], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Lentinus (genus) [taxon 5357]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12911893/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12911893/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12911893/full.md

---
Source: https://tomesphere.com/paper/PMC12911893